Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22241513 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 3/Safety & Efficacy of Esomeprazole in Infants
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Open Label Run In Esomeprazole;   Drug: Double Blind Esomeprazole;   Drug: Double Blind Placebo

Indicates status has not been verified in more than two years